Unibest

Pharmaceutical intermediates

OSIMERTINIB MESYLATE Intermediates

9 pharmaceutical intermediates for OSIMERTINIB MESYLATE. Indication: Carcinoma, Non-Small-Cell Lung.

提交项目All intermediates

About OSIMERTINIB MESYLATE

Originator
AstraZeneca
Indication
Carcinoma, Non-Small-Cell Lung
Approved Date
11/13/2015
DS/DP
07/25/2032

Available intermediates

9 intermediates currently listed for OSIMERTINIB MESYLATE. Request specifications, documentation or a quotation for any item below.

OSIMERTINIB MESYLATE intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
4-fluoro-2-Methoxy-5-nitroaniline1075705-01-9//
3-(2-chloropyriMidin-4-yl)-1-Methylindole1032452-86-0//
N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine1421372-94-2//
1,4-BenzenediaMine, N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro-1421372-67-9//
N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]benzene-1,2,4-triamine1421372-66-8//
N,N,N'-Trimethylethylenediamine142-25-6//
4-Methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile675126-26-8//
N-(3-Chloropropyl)morpholine7357-67-7//
5-hydroxy-4-methoxy-2-nitrobenzoic acid ethyl ester1146162-38-0//

Other programs under O

OfloxacinOlaparibOliceridineOmadacycline toslateOrforglipronOzenoxacin

Building toward OSIMERTINIB MESYLATE?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →